Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 119,793 | 128,656 | 113,877 | 115,978 | 114,927 |
| Cost of Goods | 54,381 | 55,613 | 46,129 | 49,577 | 48,439 |
| Gross Profit | 65,412 | 73,043 | 67,748 | 66,401 | 66,488 |
| Operating Expenses | 61,612 | 68,956 | 59,332 | 60,964 | 62,407 |
| Operating Income | 4,181 | 4,700 | 8,545 | 6,014 | 4,520 |
| Other Income | -807 | -1,069 | -1,048 | -651 | -1,656 |
| Pre-tax Income | 3,374 | 3,631 | 7,497 | 5,363 | 2,864 |
| Income Tax | 1,471 | 1,887 | 1,924 | 1,899 | 468 |
| Net Income Continuous | 1,903 | 1,744 | 5,573 | 3,464 | 2,396 |
| Net Income | $1,903 | $1,744 | $5,573 | $3,464 | $2,396 |
| EPS Basic Total Ops | 0.06 | 0.05 | 0.17 | 0.10 | 0.07 |
| EPS Basic Continuous Ops | 0.06 | 0.05 | 0.17 | 0.10 | 0.07 |
| EPS Diluted Total Ops | 0.06 | 0.06 | 0.16 | 0.10 | 0.07 |
| EPS Diluted Continuous Ops | 0.06 | 0.05 | 0.16 | 0.10 | 0.07 |
| EPS Diluted Before Non-Recurring Items | 0.22 | 0.47 | 0.28 | 0.29 | 0.16 |
| EBITDA(a) | $10,854 | $11,454 | $15,432 | $13,207 | $11,777 |